Neuronal FSTL4 negatively regulates BDNF-mediated neuron-glioma interaction.

Area of Science:

• Neuro-oncology
• Molecular biology
• Cellular interactions

Background:

• Gliomas utilize molecular pathways for growth and invasion.
• Neuron-glioma interactions are complex, with Brain-Derived Neurotrophic Factor (BDNF) playing a key role.
• Regulation of BDNF-mediated neuron-glioma cross-talk remains unclear.

Purpose of the Study:

• To investigate the role of neuronal FSTL4 in regulating BDNF-mediated neuron-glioma cross-talk.
• To explore the therapeutic potential of manipulating the FSTL4/BDNF/TrkB axis in glioma treatment.

Main Methods:

• Chemogenetic activation of primary neurons.
• CRISPR-Cas9 technology for gene knockout and activation of endogenous FSTL4.
• Co-culture systems of primary neurons and glioma cells.

Main Results:

• Activated neurons promote glioma cell proliferation via BDNF secretion, activating TrkB in glioma cells.
• Neuronal FSTL4 negatively regulates this interaction; its knockout enhances glioma cell proliferation.
• CRISPR activation of neuronal FSTL4 impairs the ability to support glioma cell proliferation.

Conclusions:

• The FSTL4/BDNF/TrkB axis is crucial for modulating neuron-glioma interactions.
• Targeting this axis with CRISPR-based tools presents a promising therapeutic avenue for glioma.